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http://www.biomedcentral.com/1471-244X/14/77RESEARCH ARTICLE Open AccessAntidepressant utilization after hospitalization with
depression: a comparison between non-Western
immigrants and Danish-born residents
Helle Wallach-Kildemoes1,2, Louise Thirstrup Thomsen3, Margit Kriegbaum1, Jørgen Holm Petersen4
and Marie Norredam3,5*Abstract
Background: Antidepressant (AD) therapy is recommended for patients 4–12 months after remission from depression.
The aim was to examine whether immigrants (refugees or family reunited immigrants) from non-Western countries
are at greater risk than Danish-born residents of 1) not initiating AD therapy after discharge and 2) early AD
discontinuation.
Methods: A cohort of immigrants from non-Western countries (n = 132) and matched Danish-born residents (n = 396)
discharged after first admission with moderate to severe depression between 1 January 1996 and 31 May 2008 was
followed in the Danish registries.
Logistic regression models were applied to explore AD initiation within 30 days after discharge, estimating odds ratio
(OR) for immigrants versus Danish-born residents.
Early discontinuation was explored by logistic regression, estimating OR for no AD dispensing within 180 days after the
first dispensing, and by Cox regression, estimating hazard ratio (HR) for discontinuation (maximum drug supply gap)
within 180 days.
Results: Immigrants had higher odds for not initiating AD treatment after discharge than Danish-born residents
(OR = 1.55; 95% CI: 1.01-2.38). When income was included in the model, the strength of the association was attenuated.
Odds for early discontinuation was non-significantly higher among immigrants than Danish-born residents (OR = 1.80;
0.87-3.73). Immigrants also had a non-significantly higher hazard of early discontinuation (HR = 1.46; 95% CI: 0.87-2.45).
Including income had only minor impact on these associations.
Conclusion: Immigrants seem less likely to receive the recommended AD treatment after hospitalization with
depression. This may indicate a need for a better understanding of the circumstances of this vulnerable group.
Keywords: Immigrants, Post-remission, Antidepressant, Ethnic disparities, Health careBackground
The number of immigrants in Denmark has grown over
the last 30 years. As of 1 January 2012, immigrants (7.9%)
and their descendants (2.5%) constituted 10.4% (580,461)
of the population [1]. Several European studies have found
an increased prevalence of self-reported depression [2,3]* Correspondence: mano@sund.ku.dk
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distribution, and reproduction in any mediumand/or psychological distress [4] in immigrant groups
compared with local born European populations, and it
has been hypothesized that loss and trauma associated
with immigration may increase the risk of depression in
vulnerable individuals [5]. In Denmark, the most frequent
countries of origin (excluding the European Union) for
immigrants are: Turkey, Iraq, Bosnia, Iran, Lebanon,
Pakistan, Afghanistan, and the former Yugoslavia [1].
In Denmark, access to health care service is formally
independent of migrant status, owing to a health care
system based on principles of free and universal accessed Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited.
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Co-payment is, however, required for important services
such as psychotherapy and prescription drugs [7].
Studies from both Denmark [8] and other countries
[9,10] indicate that immigrants or ethnic minority groups
may not receive care of the same quality as majority popu-
lations explained for example by communication difficulties
between health care staff and minority patients [11-13].
From an immigrant health perspective, it is therefore im-
portant to examine the quality of care for immigrants with
depression.
For patients with moderate to severe depression, current
guidelines recommend pharmacological treatment for at
least 4–12 months after remission to reduce the risk of
relapse [14-17]. However, studies indicate that 20–70% of
patients discontinue treatment prematurely [18-22]. Dutch,
Spanish, and American studies have found that immigrants
and/or ethnic minority patients with depression have
lower odds of initiating antidepressant (AD) treatment
[23,24] and a higher risk of early treatment discontinu-
ation [9,10,21,25,26] than the majority population. Other
studies have found ethnic differences in patients’ beliefs
and attitudes towards psychopharmacological treatment
[27,28] and ADs [29], which may influence patient medi-
cation taking behavior [30-32]. Furthermore, a Danish
register-based study among patients treated with ADs in
general practice [19] found that patients with low income
or low educational level had a higher risk of discontinuing
treatment within six months than patients with higher
socio-economic position (SEP). This study also found that
foreign citizens had a twofold higher risk than Danish
citizens of discontinuing AD treatment within six months
[19], but this finding was not further explored or discussed
by the authors. Since non-Western immigrants in Denmark
on average have lower SEP than Danish-born residents
[33], this may contribute to a higher risk of non-initiation
or early discontinuation of AD treatment in the immigrant
population.
Nevertheless, knowledge on psychiatric morbidity and
psychopharmacological treatment among immigrants in
Denmark is scarce. Folmann and Joergensen [34] found
that first- and second-generation immigrants from
several non-Western countries had lower consump-
tion of ADs than Danish-born residents, even in mi-
nority groups who were more frequently in contact
with the psychiatric system than Danish-born residents
[34]; this could indicate an under-treatment in the minor-
ity groups.
The aim of the present study was to examine whether
immigrants from non-Western countries are at greater risk
than Danish-born residents of not receiving pharmaco-
logical therapy according to guidelines after hospitalization
for moderate to severe depression. We focused on two re-
search questions:1) Are immigrants at greater risk than Danish-born
residents of not initiating AD treatment after
discharge?
2) Among those initiating therapy, are immigrants at
greater risk for early AD discontinuation than
Danish-born residents?
Methods
Study population and design
We performed a cohort study based on register-data on
immigrants and Danish-born reference residents. Im-
migrants were defined as persons born abroad who had
acquired Danish residence permission as refugees or
through family reunification. Work and student migrants
were not included. Furthermore, we did not include immi-
grants born in Western countries (defined as the EU coun-
tries, Andorra, Iceland, Lichtenstein, Monaco, Norway, San
Marino, Switzerland, the Vatican, Canada, the United
States, Australia, and New Zealand), assuming that these
immigrants due to shared ethnic, cultural, political and so-
cioeconomic characteristics may experience fewer barriers
when faced with the Danish health care system, and may
resemble Danish-born residents more in medication-
taking behavior than immigrants from other countries.
Danish-born residents were defined as persons born in
Denmark by Danish-born parents.
The immigrant population was established using data
from the Statistical Department at the Danish Immigration
Service and included all refugees and family reunified
individuals aged >17 years who received residence permits
between 1 January 1993 and 31 December 1999. Using data
from the Demographic Database at Statistics Denmark,
a Danish-born reference cohort was established corre-
sponding to four age- and sex-matched Danish-born
residents per immigrant. In total, the original cohort
consisted of 312,300 individuals. For details see Norredam
et al. [35,36].
By means of encrypted civil registration numbers, the
cohort was followed in the nation-wide Danish registries,
including the Danish Psychiatric Central Register [37],
the Danish National Patient Register [38], the Danish
National Prescription Registry (DNPR) [39], and the socio-
demographic registries (date of death, migration, and socio-
economic information) [40].
The Danish Psychiatric Central Register [37] contains
data on all admissions to Danish psychiatric in-patient
facilities since 1969. For the purpose of this study, we
selected cohort members who had been admitted with
moderate to severe single episode or recurrent depression
ICD-10 diagnoses F32-F33, excluding patients with mild
depression (F32.0, F32.00, F32.01, F33.0, F33.00, and F33.01)
and patients currently in remission (F33.4). We selected
only Danish-born residents and immigrants with longer-
term admissions (at least 3 days) between 1 January 1996
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The first admission satisfying these criteria for each pa-
tient will hereafter be referred to as the index admission.
Information on AD dispensing was followed in the DNPR
containing individual-level information on dispensed pre-
scriptions from Danish outpatient pharmacies [39]. ADs
were defined as pharmaceuticals in Anatomical Therapeu-
tical Chemical (ATC) class N06A [41].
To explore whether immigrants and Danish-born resi-
dents were equally likely to receive the recommended AD
treatment after discharge from psychiatric hospitalization,
we followed the cohort in the registries until: AD dispens-
ing, hospitalization, death, or emigration. Treatment initi-
ation and early discontinuation were applied as outcome
measures.
Exclusion criteria
In order to restrict the study population to patients with
incident episodes of depression, we excluded patients pre-
viously hospitalized with depression (n = 55) and patients
with AD dispensing (n = 1,161) within six months prior to
the index admission, Figure 1. To ensure full register
information one year before the index admission, we also
excluded individuals with less than one year’s residence
permission or migration one year before the index admis-
sion (n = 27). Furthermore, we excluded individuals who
filled prescriptions during the index admission more than
one day before discharge (n = 14), and patients who died or
emigrated within the first 30 days after discharge (n = 6).
Finally, since the DNPR does not contain information
on drugs administered under hospitalization, we excluded
patients with readmissions to any hospital (psychiatric
or otherwise) during the first 30 days after discharge
and before purchase of ADs (n = 10), resulting in a study
population of 528 individuals (132 immigrants and 396
Danish-born residents), Figure 1.
Outcomes
Treatment initiation: Patients were considered to have
initiated treatment if they had filled a prescription for
ADs within 30 days after discharge (index prescription).
Prescriptions filled the day before discharge were included,
assuming that getting the required medication at the
pharmacy just before discharge is part of a smooth dis-
charge from psychiatric hospitalization (10 patients filled a
prescription one day before discharge).
Early treatment discontinuation was explored in the
cohort of patients initiating AD treatment within 30 days
after discharge (n = 378), and defined as discontinuation
within 180 days after the index prescription. Two methods
were applied to assess early discontinuation: the minimum
refill method [42] and the maximum gap method [43,44].
in line with Hansen and colleagues [19], patients were
considered to have discontinued early if no further ADdispensing was observed within 180 days after the first
dispensing. In this analysis, we excluded individuals
who died (n = 1), emigrated (n = 1), or were hospitalized
(n = 64) within 180 days after discharge, without prior
filling of a second AD prescription. This resulted in a
minimum refill study population of 312 individuals.
According to the maximum gap method [44], treatment
is considered as discontinued if gaps in drug supply ex-
ceeds a predefined time period (grace period). In the
present study, the discontinuation date among individuals
having initiated therapy after discharge (n = 378) was de-
fined as the first date when the gap between two consecu-
tive dispensings exceeded the number of tablets in the
previous dispensing plus a 50% grace period. Sensitivity
analyses were performed using grace periods of 33% and
70% of number of tablets on the previous prescription.
Since the DNPR does not contain information on pre-
scribed daily dose [39], we assumed in line with Rosholm
and colleagues [45] that a prescribed daily dose of AD
therapy corresponds to one tablet per day. If more than
one AD category or two packets of AD of the same category
with different strength were dispensed the same day, we
based our calculations on the largest pack size.
Confounders and mediators
Sex and age (at the time of index admission) were included
as confounders. All other co-variables were viewed as
potential mediators of an association between patient
origin and treatment initiation/discontinuation.
Patient income was used as an indicator of SEP. From
the registers we retrieved information on annual personal
income (including all earnings, capital income, and social
transfers) in the year before the index admission.
From the Psychiatric Central Register, we obtained in-
formation on depression severity (moderate (ICD-10 codes
F32.1, F33.1), severe (F32.2-F32.3, F33.2-F33.3), or other/
unspecified (F32.8-F32.9, F33.8-F33.9)), and type of care to
which patients were referred after discharge (coded as
general practitioner, specialized treatment, no medical
follow-up, or other/unknown). For patients who initiated
antidepressant treatment, we included information from
the DNPR on type of antidepressant prescribed on the first
prescription after discharge tricyclic antidepressants (TCAs,
ATC-class N06AA) or newer ADs (ATC-class N06AB,
N06AX).
Statistical analysis
Preliminary analyses of bivariate associations were per-
formed using Fisher’s exact test for binary/nominal
variables and gamma-test for ordinal variables. Logistic
regression models were applied to assess whether post-
hospitalization AD treatment was initiated independently
of patient-origin, estimating odds ratio (OR) for not ini-
tiating AD treatment within 30 days after discharge for
Figure 1 Flowchart of the population included as study population.
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gously, logistic regression models were applied to test early
discontinuation according to the minimum refill method,
estimating OR for not filling a second AD prescription
within 180 days after the first dispensing (n = 312). Model
calibration was performed using Hosmer and Lemeshow’s
goodness-of-fit test.
Cox proportional hazard regression analyses were ap-
plied to assess whether early discontinuation was inde-
pendent of patient origin, estimating hazard ratio (HR)
for discontinuation defined according to the maximum
gap method. Number of days since first AD dispens-
ing was used as the underlying time variable with a
follow-up time up to 180 days. Participants were cen-
sored at date of death, emigration (n = 1) or hospital
admission (n = 114) before the end of follow-up. The
proportional hazard assumption was tested by includ-
ing the term [log(time)*patient origin] in the model.
There was no evidence of violation of the proportionality
assumption.Applying a 95% confidence interval (CI), we first ex-
amined the effect of patient origin on treatment initiation/
discontinuation, controlling for confounders (age and sex).
Subsequently, we included potential intermediate variables
in the regression models to examine their mediating effect
[46]. Income was included as a categorical variable, divided
into four groups: <100,000 Danish Krone (DKK); 100,000-
199,999 DKK; 200,000-299,999 DKK; and ≥300,000 DKK
(100 EUR = 746 DKK; November 2012). Age was included
as a continuous variable. Use of alternative specifications
did not alter conclusions.
All statistical analyses were carried out in SAS, version
9.2. Register-based studies in Denmark do not require
approval by an ethics board, but the study was approved
by the Danish National Data Protection Agency.
Results
Description of study population
Table 1 presents the main characteristics of the study
population of patients discharged after hospitalization
Table 1 Characteristics of study population (n = 528)
Population characteristics Danish-born
residents
n = 396 (%)
Non-Western
immigrants
n = 132 (%)
P1
Sex
Female 232 (58.6%) 78 (59.1%) 0.92
Age at index admission (years)
18-29 98 (24.8%) 17 (12.9%) 0.10
30-39 158 (39.9%) 65 (49.2%)
40-49 87 (22.0%) 33 (25.0%)
50-59 26 (6.6%) 11 (8.3%)
60-86 27 (6.8%) 61 (4.6%)
Annual income2
<13,405 EUR 52 (13.1%) 31 (23.5%) <0.0001
13,405-26,809 EUR 182 (46.0%) 76 (57.6%)
26,810-40,214 EUR 120 (30.3%) 21 (15.9%)
≥40,215 EUR 42 (10.6%) 4(3.0%)
Severity of depression at admission
Moderate 185 (46.7%) 51 (38.6%) 0.27
Severe 179 (45.2%) 69 (52.3%)
Other type/unspecified 32 (8.1%) 12 (9.1%)
Type of outpatient care referred to after discharge
General practitioner 142 (35.9%) 54 (40.9%) 0.46
Specialized treatment 240 (60.6%) 75 (56.8%)
No medical follow-up/
Other/unknown
14 (3.5%) 3 (2.3%)
Post-discharge AD treatment
No treatment initiation within
30 days
104 (26.3%) 46 (34.8%) 0.07
Early discontinuation
(minimum refill, n = 312)
28 (11.6%) 13 (18.3%) 0.16
Type of AD on first prescription after discharge
TCA3 43 (14.7%) 12 (14.0%) 1.00
Newer ADs4 249 (85.3%) 74 (86.1%)
AD Antidepressant, EUR Euro, TCA Tricyclic antidepressant.
1Two-sided Fisher’s exact test (two-sided gamma-test for ordinal variables).
2100 EUR = 746 Danish Krone (DKK) (November 2012).
3ATC codes: N06AA04, N06AA09-10, N06AA12, N06AA16.
4ATC codes: N06AB03, N06AB04-10, N06AX03, N06AX11, N06AX16, N06AX21.
Table 2 Distribution of non-Western immigrants by region
of origin (n = 132)
Region N (%)
Eastern Europe (excl. Former Yugoslavia) 5 (3.8%)
Former Yugoslavia
Bosnia-Herzegovina 50 (37.9%)





Other Middle East 8 (6.1%)
Africa
Somalia 5 (3.8%)
Other African countries 9 (6.8%)
South- and Middle America 2 (1.5%)
Asia 5 (3.8%)
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post-hospitalization AD treatment. For both immigrants
and Danish-born residents, the majority of the population
was younger (18–39 years) and female. A higher propor-
tion of immigrants than Danish-born residents were in
lower income groups (p < 0.001). There were no significant
differences between immigrants and Danish-born residents
regarding depression severity, type of AD on first prescrip-
tion, or type of care after discharge. Therefore, income
was the only covariate included as a potential mediator in
subsequent multivariate analyses [46].Table 2 presents the distribution of immigrants (n = 132)
by their region of origin. The immigrants mainly originated
in the Former Yugoslavia (n = 60, 45.5%) and the Middle
East (n = 46, 34.9%). When looking at the specific country
of origin, 37.7% (n = 50) of the immigrants were born in
Bosnia-Herzegovina, 16.7% (n = 22) in Iraq, 7.6% (n = 10) in
Iran, 4.5% (n = 6) in Turkey, and 3.8% (n = 5) in Somalia.
Treatment initiation
A higher proportion of immigrants (34.8%) than Danish-
born patients (26.3%) did not initiate AD treatment within
30 days after discharge (p = 0.07), Table 1. Table 3 shows
the multivariate analyses of not initiating AD treatment.
When adjusting for gender and age, immigrants had higher
odds for not initiating AD treatment than Danish-born
residents (OR = 1.55; 95% CI: 1.01-2.38). When income
was included as a potential mediator, the strength of the
association between patient origin and treatment initiation
was attenuated (1.31; 0.84-2.03) and was not statistically
significant. Assuming the same gender pattern across the
two ethnic groups, the analysis also showed that men had
significantly higher odds than women for not initiating
AD treatment (1.59; 1.08-2.34), Table 3.
Early treatment discontinuation
A higher proportion of immigrants (18.3%) than Danish-
born residents (11.6%) discontinued AD treatment early
according to the minimum refill method, but this difference
was not statistically significant, p = 0.16 (Table 1). Table 4
presents the multivariate analyses of early discontinuation
defined according to the minimum refill method and the
maximum gap method, respectively. Adjusting for age and
gender in the minimum refill approach (model A1), odds
Table 3 Odds Ratio (OR) for not initiating AD treatment
within 30 days after discharge Non-Western immigrants
are compared with Danish-born residents (n = 528,
events = 150)
Model 1 Model 2
Patient characteristic OR (95% CI) OR (95% CI)
Patient origin
Danish-born residents (ref) 1 1
Non-Western immigrants 1.55 (1.01-2.38) 1.31 (0.84-2.03)
Sex
Female (ref) 1 1
Male 1.59 (1.08-2.34) 1.71 (1.15-2.53)
Age
Continuous 0.98 (0.96-1.00) 0.98 (0.97-1.00)
Annual income1
<13,405 EUR (ref) 1
13,405-26,809 EUR 0.98 (0.58-1.66)
26,810-40,214 EUR 0.48 (0.25-0.89)
≥40,215 EUR 0.29 (0.11-0.79)
AD antidepressant treatment, CI Confidence interval, EUR Euro, OR Odds ratio.
Model 1: OR for not initiating treatment, including patient origin, age and sex.
Model 2: OR for not initiating treatment, including patient origin, age, sex
and income.
1100 EUR = 746 Danish Krone (DKK) (November 2012).
Table 4 Early discontinuation of AD treatment within 180 days
and B) The maximum gap method (50% supply gap)
A. Minimum refill method
OR (95% CI)
n = 312;events = 41
Patient characteristic Model A1 Model
Patient origin
Danish-born residents (ref) 1 1
Non-Western immigrants 1.80 (0.87-3.73) (p = 0.12) 1.69 (0.79-3.59)
Sex
Female (ref) 1 1
Male 1.82 (0.93-3.55) (p = 0.08) 1.90 (0.96-3.76)
Age
Continuous 0.98 (0.95-1.01) (p = 0.23) 0.98 (0.95-1.01)
Annual income1
<13,405 EUR (ref) 1
13,405-26,809 EUR 0.73 (0.29-1.81)
26,810-40,214 EUR 0.43 (0.15-1.28)
≥40,215 EUR 0.81 (0.23-2.87)
AD Antidepressant, EUR Euro, HR Hazard ratio, OR Odds ratio.
Model A1: OR for not refilling a prescription within 180 days after the first prescript
Model A2: OR for not refilling a prescription within 180 days after the first prescript
Model B1: HR for not refilling a prescription within the allowed supply gap, includin
Model B2: HR for not refilling a prescription within the allowed supply gap, includin
1100 EURO = 746 Danish Krone (DKK) (November 2012).
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immigrants than Danish-born residents (OR = 1.80; 95%
CI: 0.87-3.73). When income was included in the model,
the strength of the association between patient origin and
early treatment discontinuation was only slightly attenuated,
and income was not itself a significant predictor of early
discontinuation (model A2).
Analyses based on the maximum gap method revealed
similar results. Applying a supply gap of maximum 50%
(model B1), immigrants were more likely to discontinue
AD therapy prematurely than Danish-born residents, but
this difference did not reach statistical significance (HR =
1.46; 95% CI: 0.87-2.45). Including income only marginally
changed the strength of the association (model B2). Sensi-
tivity analyses using maximum supply gaps of 30% and
70% indicated that point estimates were relatively robust
to the gap definition, although the association between
patient origin and early discontinuation was attenuated




In this register-based cohort study, a lower proportion
of non-Western immigrants than Danish-born residents
initiated AD treatment within 30 days after discharge
from hospitalization with depression (34.8% versus 26.3%).after discharge, applying A) The minimum refill method
B. Maximum gap method
HR (95% CI)
n = 378;events = 72
A2 Model B1 Model B2
1 1
(p = 0.17) 1.46 (0.87-2.45) (p = 0.15) 1.52 (0.89-2.61) (p = 0.13)
1 1
(p = 0.06) 1.58 (0.99-2.52) (p = 0.05) 1.59 (0.99-2.55) (p = 0.05)
(p = 0.19) 0.99 (0.97-1.01) (p = 0.17) 0.98 (0.96-1.00) (p = 0.12)
1
(p = 0.93) 0.75 (0.40-1.40) (p = 0.36)
(p = 0.13) 0.57 (0.28-1.18) (p = 0.13)
(p = 0.75) 1.24 (0.53-2.87) (p = 0.62)
ion, including patient origin, age and sex.
ion, including patient origin, age, sex and income.
g patient origin, age and sex.
g patient origin, age, sex and income.
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of the immigrants discontinued treatment within 180 days
(18.3% versus 11.6%).
Immigrants were significantly less likely than Danish-
born residents to initiate AD treatment after discharge.
When including income in the model, the difference in
treatment initiation was attenuated, indicating that income
partly mediated the observed difference. Applying two dif-
ferent methods for measuring treatment discontinuation,
both analyses showed that immigrants were more likely to
discontinue AD treatment early than Danish-born patients,
but the observed trends were not statistically significant.
Income did not seem to mediate the trend toward ethnic
disparities in premature discontinuation.
Initiation and early discontinuation of AD treatment
Our findings are in accordance with previous studies
indicating that minority groups are at higher risk than
majority populations of not receiving the recommended
AD treatment for depression [9,10,19,21,24-26,47,48]. How-
ever, to our knowledge no prior studies have restricted
the study population to patients discharged from hospi-
talization with moderate to severe depression and explored
both initiation of AD treatment after hospitalization and
early discontinuation of therapy. In line with our study, a
register-based study from the US [25] showed that minor-
ities (African Americans, Asians, and Hispanics) with newly
diagnosed depression were less likely to receive adequate
acute- and post-remission antidepressant treatment than
the majority population. A survey-based US study on
outpatients admitted to mental health clinics with major
depression [24] showed that the majority population (white
Americans) were almost three times more likely to be rec-
ommended AD treatment than the minority population.
In a recent register-based cohort study from Spain, Cruz
and colleagues found that immigrant patients were more
likely than native patients to discontinue AD treatment
during follow-up, and nearly half of the immigrant pa-
tients discontinued treatment within the first month [26].
Although studies in this field are difficult to compare due
to different health care- and reimbursement systems, dif-
ferent types of ethnic minorities, different clinical settings,
and different approaches for measuring AD initiation
and discontinuation, the studies all indicate that minority
groups are less likely to receive adequate pharmacological
therapy for depression than the majority population
[9,10,19,21,24-26,47,48].
Adding to previous findings from other countries, our
Danish study indicates that even in a predominantly
tax-financed health care system, ethnic disparities appear
to exist as to initiation of AD treatment when comparing
first-generation immigrants with Danish-born patients. As
the physician responsible for psychiatric discharge often
also is responsible for planning out-patient treatment, thefirst AD prescription is most likely prescribed by the
hospital psychiatrist. Thus, the high proportion of patients
(independent of origin) not initiating therapy could indi-
cate that psychiatric wards are confronted with challenges
of preparing patients better for the post-hospitalization
pharmacological therapy. The fact that immigrants have
lower odds for initiating therapy could indicate that cul-
tural- or migration-related factors are at play (see Potential
Mechanisms below).
To our knowledge no Danish studies have previously
explored ethnic differences in initiation of AD treatment
after psychiatric hospitalization. Applying the same mini-
mum refill definition of early AD discontinuation as in
our study, Hansen and colleagues [19] use Danish/foreign
citizenship rather than country of birth as a measure of
patient origin in the aforementioned Danish study on
predictors for early AD discontinuation. In contrast to
our study, the study by Hansen and colleagues includes
all patients initiating AD treatment in general practice,
i.e. also when AD treatment is initiated for indications
other than moderate to severe depression, such as mild
depression or anxiety disorders. As a consequence, their
study population is very large compared to our study,
which may partly explain their finding of a significantly
higher odds for early discontinuation among foreign citi-
zens compared with Danish citizens (OR = 1.99, 99% CI:
1.18-3.37), whereas the association in our study was
non-significant (OR = 1.80, 95% CI: 0.87-3.73).
Potential mechanisms for ethnic disparities in AD treatment
To improve mental health care for immigrant populations,
it is important to uncover factors explaining ethnic dis-
parities in the recommended post-hospitalization AD
treatment. We explored to what extent income mediated
the differences in AD treatment according to patient origin.
In line with two previous Danish studies on ethnic dispar-
ities in pharmacological therapy for cardiovascular disease
[8] and diabetes [49], we found that income only to a lim-
ited extent mediated the observed ethnic disparities. While
some studies have shown that adherence to pharmaco-
logical therapy increases with income [19,21], other studies
have found that adherence decreases with increasing SEP
[50]. It may be speculated that individuals with high SEP
could be less likely to accept the side effects of AD
treatment, since they have the possibility to pay for costly
alternatives such as psychotherapy. Thus, the relationship
between SEP and adherence is not straightforward, which
may explain the limited mediating effect of this variable.
Our analysis also indicated that the ethnic disparities in
post-hospitalization AD treatment were not explained by
depression severity, type of AD treatment (newer ADs
versus TCA), or type of out-patient care after discharge.
Hence, factors which could not be thoroughly examined
in the present register-based study seem to be at play as to
Wallach-Kildemoes et al. BMC Psychiatry 2014, 14:77 Page 8 of 11
http://www.biomedcentral.com/1471-244X/14/77the ethnic disparities in post-hospitalization AD therapy.
Such potential factors may include patient beliefs and
social norms regarding AD treatment [30-32]; health care
providers’ attitudes towards immigrant patients [12]; and
the cross-cultural communication skills of health care pro-
viders [11]. Moreover, ethnic differences in the acceptability
of AD treatment [27-29], differences in the beliefs about
the causes of and potential cures for illness [51,52], or dif-
ferences in the social stigma associated with depression
and AD treatment [53] may influence patient medication-
taking behavior [30-32]. Furthermore, stressors related to
migration [54,55] may be hypothesized to influence immi-
grant patients’ mental resources to cope with disease and
adhere to treatment. As regards the health care provider,
the ability to establish a patient-provider relationship
characterized by clear communication, trust and mutual
understanding is essential to ensuring patient adherence
[18,20,54,56,57]. Several studies have found that meetings
between health care professionals and immigrant patients
may sometimes be characterized by miscommunication,
misunderstandings and frustration [11,12,58,59]. In this
regard, access to professional interpreter assistance is likely
to be an important organizational strategy to ensure quality
of care for immigrant patients [60]. Furthermore, poor
collaboration and coordination between primary and
secondary health care sector may increase the risk of
treatment discontinuation after discharge from psychiatric
hospital. This may especially be the case for immigrant
patients, who may lack knowledge of the structure and
functioning of the Danish health care system, since im-
migrants are not systematically introduced to the health
care system [61].
In a previous study [36], we demonstrated that immi-
grants are more frequently subjected to coercive measures
during psychiatric hospitalization than native Danes,
potentially due to delayed admission to psychiatric wards
or to cultural barriers and misunderstandings [58]. Hence,
the observed excess in coercive measures applied to ethnic
minorities [36] may introduce mistrust and skepticism
towards the pharmacological treatment recommended
by health care professionals. Unfortunately, we did not have
access to information regarding coercive measures for
the entire observation period in the present study. Thus,
further research is needed to uncover to what extent use
of coercive measures in psychiatry increases the risk of
non-adherence to post-hospitalization pharmacological
therapy.
Strengths and limitations of the study
The main strength of our study is the linkage of
individual-level data from various Danish registers. This
allowed us to establish a homogenous cohort of individuals
hospitalized with moderate-severe depression that could be
followed for subsequent AD dispensing and other registerinformation without the risk of selection or information
bias.
However, we also acknowledge several limitations of
our study. First of all, due to our small sample size, we
were unable to conduct analyses according to the im-
migrants’ specific country of origin. Immigrants from
non-Western countries are a heterogeneous group with a
variety of social, linguistic, ethnic and religious backgrounds,
and medication-taking behavior may differ between immi-
grants of different origin [8,34]. Therefore, it may be con-
sidered simplistic to regard immigrants as one group. Even
an immigrant’s specific country of origin may be a very
crude proxy for ethnicity [62,63]. It has been argued
that self-reported ethnicity is a more precise, dynamic
and non-discriminatory measure [62,63]. However, self-
reported ethnicity was not available in the present register-
based study.
Secondly, our relatively small sample size also meant
that we had few discontinuation events. This increased
the risk of not finding statistically significant differences
in AD treatment according to patient origin and resulted in
wide 95% confidence intervals in the multivariate models.
Lack of statistical power is a general problem when con-
ducting epidemiological studies on immigrants, not least
in countries like Denmark with relatively small immigrant
populations – especially when the immigrant population
is limited to individuals acquiring residence permits as
refugees or by family reunification [36].
We opted to examine the robustness of our results by
using two different approaches for evaluating early discon-
tinuation and by conducting sensitivity analyses, which
allowed varying lengths of gaps in medication supply. Ap-
plying data from DNPR on dispensed prescription drugs
as a proxy for whether patients receive the recommended
pharmacological treatment rests upon several assumptions
[39]: 1) patients consume the redeemed medicine (which
we assume here), and 2) any missing redemption is caused
either by the physician (no prescription prescribed during
the meeting with the patient) or by the patient failing
to fill the prescription. Both aspects of missing drug re-
demption are of interest, but in this study we could not
distinguish between the two.
Thirdly, we applied personal income as the only indica-
tor for SEP. Applying educational level as an SEP indicator
could have provided the study with supplementary aspects,
since different indicators of SEP may represent different
mechanisms through which SEP impacts on treatment
initiation and discontinuation [64]. While an association
between income and educational level exists in native
born populations, the same association may not exist in
immigrant populations due to difficulties in obtaining
jobs related to obtained education. However, we were not
able to include this variable in the analyses as the educa-
tional level of immigrants is incompletely recorded in the
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income as an indicator for economic capacity should also
be recognized, especially when comparing ethnic groups
with different family structures. In our analysis, the lowest
income group tended to have less economic barriers for
buying medicines than the medium income groups. This
paradox may be explained by the fact that personal income
does not include special social transfers such as rent sub-
sidy and supplementary drug reimbursement (requiring
application). If Danish-born residents are more likely than
immigrants to receive supplementary reimbursement for
out-of-pocket drug expenditures, we may have underesti-
mated income related disparities.
Fourthly, our study includes only information on medi-
cine purchased in Denmark. However, a recent Danish
study [65] showed that immigrants in Denmark tend to
buy medicines abroad, potentially explaining part of the
observed disparities as regards to AD prescription dis-
pensed at Danish pharmacies.
Lastly, since our study included refugees and family
reunited immigrants only, our findings may not be
generalizable to other immigrant groups such as work
migrants.
Implications
Although our small sample size warrants caution when
drawing conclusions, the results of our study indicate a
need for interventions to improve communication between
health care professionals and immigrant patients. An
important element in this may be to ensure professional
interpreter assistance for immigrant patients with limited
proficiency in the local language [60]. Nevertheless, in
2011, user-fees (now abolished) were introduced for
interpreter assistance to immigrants with permanent resi-
dency in Denmark. It has recently been shown that these
user fees resulted in less use of interpreters, especially
in lower income groups [66]. A close and genuine pa-
tient/provider dialogue about the planned treatment
after hospitalization is likely to be crucial for ensuring
AD adherence after discharge [18,57]. Furthermore, our
results point to a need for efforts to improve collaboration
between primary and secondary health care providers
in order to ensure treatment continuity after hospital
discharge [67], e.g. by improved communication about
patients’ discharge plans between inpatient staff and
outpatient clinicians [68].
Conclusion
Compared to Danish-born residents, refugees and family
reunited immigrants from non-Western countries seem to
be less likely to receive the recommended AD treatment
after hospitalization with moderate to severe depression.
This is especially true for the first AD dispensing after dis-
charge, indicating special communication problems whennegotiating pharmacological therapy with immigrant
patients under hospitalization, along with a need for im-
proving collaboration between secondary and primary care
to ensure continuity in treatment. Albeit not statistically
significant, we also observed a tendency towards ethnic
disparities in early AD treatment discontinuation. Only
a small part of the ethnic disparities were explained by
income differences.
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